What is the expected CAGR for the Medical Device Design and Development Services Market from 2025 to 2035?

The expected CAGR for the Medical Device Design and Development Services Market during the forecast period 2025 - 2035 is 13.6%. Read More

Which companies are considered key players in the Medical Device Design and Development Services Market?

Key players in the market include Medtronic, Boston Scientific, Johnson & Johnson, Stryker, and Abbott Laboratories. Read More

What segment of services had the highest valuation in 2024 within the Medical Device Design and Development Services Market?

The Designing & Engineering segment had the highest valuation of 4.96 USD Billion in 2024. Read More

How much is the Cardiovascular Devices segment projected to grow by 2035?

The Cardiovascular Devices segment is projected to grow from 1.5 USD Billion in 2024 to 6.5 USD Billion by 2035. Read More

What is the projected valuation for the Machining segment by 2035?

The Machining segment is projected to reach a valuation of 12.73 USD Billion by 2035. Read More

Which therapeutic area is expected to have the highest market valuation in 2035?

The Cardiovascular therapeutic area is expected to have the highest market valuation of 20.17 USD Billion in 2035. Read More

What is the projected growth for the Drug Delivery Devices segment from 2024 to 2035?

The Drug Delivery Devices segment is projected to grow from 1.0 USD Billion in 2024 to 4.5 USD Billion by 2035. Read More

What is the expected market size for Medical Device Companies by 2035?

The expected market size for Medical Device Companies is projected to reach 32.0 USD Billion by 2035. Read More

Medical Device Design Development Services Market

Q: What is the projected market valuation for the Medical Device Design and Development Services Market in 2035?

The projected market valuation for the Medical Device Design and Development Services Market in 2035 is 50.43 USD Billion. Read More

Q: What was the market valuation for the Medical Device Design and Development Services Market in 2024?

The market valuation for the Medical Device Design and Development Services Market in 2024 was 12.4 USD Billion. Read More

Medical Device Design and Development Services Market Research Report Information By Service (Designing & Engineering, Machining, Molding and Packaging), By Medical Devices (Cardiovascular Devices (Ventricular Assist Devices, Total Artificial Hearts, Pacemakers, Implantable Cardioverter Defibrillators (ICDs), Cardiac Loop Recorders, Holter Monitors, Event Monitors, ECMO Systems, Consumables), POC Diagnostic Equipment (Blood Glucose Monitor, Blood Analyzer, Blood Pressure Monitor, Pregnancy Test Kit, Infectious Diseases Testing), Hb1Ac Testing (Coagulation Testing Kit, Cardiac Markers Test, Thyroid Stimulating Hormone Test, Others), Market Forecast Till 2035

Forecast Period

2025 - 2035

CAGR

13.6%

2024 Market Size

$ 12.4 Billion

2035 Market Size

$ 50.43 Billion

Medical Device ● Updated April 2026 Report ID: MRFR/MED/20410-HCR | Pages: 128 | Author: Nidhi Mandole, Rahul Gotadki

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Service (USD Billion)
  1. 4.1.1 Designing & Engineering
  2. 4.1.2 Machining
  3. 4.1.3 Molding
  4. 4.1.4 Packaging
2. 4.2 Healthcare, BY Medical Devices (USD Billion)
  1. 4.2.1 Cardiovascular Devices
  2. 4.2.2 POC Diagnostic Equipment
  3. 4.2.3 Hb1Ac Testing
  4. 4.2.4 Drug Delivery Devices
  5. 4.2.5 Orthopedic Devices
  6. 4.2.6 Dental Devices
  7. 4.2.7 Surgical Devices
  8. 4.2.8 Imaging Devices
  9. 4.2.9 Sleep & Respiratory Devices
  10. 4.2.10 Ophthalmology Devices
  11. 4.2.11 Endoscopy
  12. 4.2.12 Diabetes Care
  13. 4.2.13 Cochlear Implants
  14. 4.2.14 Neurostimulators
  15. 4.2.15 Others
3. 4.3 Healthcare, BY Therapeutic Area (USD Billion)
  1. 4.3.1 Cardiovascular
  2. 4.3.2 Diagnostic
  3. 4.3.3 Others
4. 4.4 Healthcare, BY End-Use (USD Billion)
  1. 4.4.1 Medical Device Companies
  2. 4.4.2 Biotechnology Companies
5. 4.5 Healthcare, BY Region (USD Billion)
  1. 4.5.1 North America
    1. 4.5.1.1 US
    2. 4.5.1.2 Canada
  2. 4.5.2 Europe
    1. 4.5.2.1 Germany
    2. 4.5.2.2 UK
    3. 4.5.2.3 France
    4. 4.5.2.4 Russia
    5. 4.5.2.5 Italy
    6. 4.5.2.6 Spain
    7. 4.5.2.7 Rest of Europe
  3. 4.5.3 APAC
    1. 4.5.3.1 China
    2. 4.5.3.2 India
    3. 4.5.3.3 Japan
    4. 4.5.3.4 South Korea
    5. 4.5.3.5 Malaysia
    6. 4.5.3.6 Thailand
    7. 4.5.3.7 Indonesia
    8. 4.5.3.8 Rest of APAC
  4. 4.5.4 South America
    1. 4.5.4.1 Brazil
    2. 4.5.4.2 Mexico
    3. 4.5.4.3 Argentina
    4. 4.5.4.4 Rest of South America
  5. 4.5.5 MEA
    1. 4.5.5.1 GCC Countries
    2. 4.5.5.2 South Africa
    3. 4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medtronic (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Boston Scientific (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Johnson & Johnson (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Stryker (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Abbott Laboratories (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 B. Braun Melsungen AG (DE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Siemens Healthineers (DE)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 GE Healthcare (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Philips Healthcare (NL)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY SERVICE
4. 6.4 US MARKET ANALYSIS BY MEDICAL DEVICES
5. 6.5 US MARKET ANALYSIS BY THERAPEUTIC AREA
6. 6.6 US MARKET ANALYSIS BY END-USE
7. 6.7 CANADA MARKET ANALYSIS BY SERVICE
8. 6.8 CANADA MARKET ANALYSIS BY MEDICAL DEVICES
9. 6.9 CANADA MARKET ANALYSIS BY THERAPEUTIC AREA
10. 6.10 CANADA MARKET ANALYSIS BY END-USE
11. 6.11 EUROPE MARKET ANALYSIS
12. 6.12 GERMANY MARKET ANALYSIS BY SERVICE
13. 6.13 GERMANY MARKET ANALYSIS BY MEDICAL DEVICES
14. 6.14 GERMANY MARKET ANALYSIS BY THERAPEUTIC AREA
15. 6.15 GERMANY MARKET ANALYSIS BY END-USE
16. 6.16 UK MARKET ANALYSIS BY SERVICE
17. 6.17 UK MARKET ANALYSIS BY MEDICAL DEVICES
18. 6.18 UK MARKET ANALYSIS BY THERAPEUTIC AREA
19. 6.19 UK MARKET ANALYSIS BY END-USE
20. 6.20 FRANCE MARKET ANALYSIS BY SERVICE
21. 6.21 FRANCE MARKET ANALYSIS BY MEDICAL DEVICES
22. 6.22 FRANCE MARKET ANALYSIS BY THERAPEUTIC AREA
23. 6.23 FRANCE MARKET ANALYSIS BY END-USE
24. 6.24 RUSSIA MARKET ANALYSIS BY SERVICE
25. 6.25 RUSSIA MARKET ANALYSIS BY MEDICAL DEVICES
26. 6.26 RUSSIA MARKET ANALYSIS BY THERAPEUTIC AREA
27. 6.27 RUSSIA MARKET ANALYSIS BY END-USE
28. 6.28 ITALY MARKET ANALYSIS BY SERVICE
29. 6.29 ITALY MARKET ANALYSIS BY MEDICAL DEVICES
30. 6.30 ITALY MARKET ANALYSIS BY THERAPEUTIC AREA
31. 6.31 ITALY MARKET ANALYSIS BY END-USE
32. 6.32 SPAIN MARKET ANALYSIS BY SERVICE
33. 6.33 SPAIN MARKET ANALYSIS BY MEDICAL DEVICES
34. 6.34 SPAIN MARKET ANALYSIS BY THERAPEUTIC AREA
35. 6.35 SPAIN MARKET ANALYSIS BY END-USE
36. 6.36 REST OF EUROPE MARKET ANALYSIS BY SERVICE
37. 6.37 REST OF EUROPE MARKET ANALYSIS BY MEDICAL DEVICES
38. 6.38 REST OF EUROPE MARKET ANALYSIS BY THERAPEUTIC AREA
39. 6.39 REST OF EUROPE MARKET ANALYSIS BY END-USE
40. 6.40 APAC MARKET ANALYSIS
41. 6.41 CHINA MARKET ANALYSIS BY SERVICE
42. 6.42 CHINA MARKET ANALYSIS BY MEDICAL DEVICES
43. 6.43 CHINA MARKET ANALYSIS BY THERAPEUTIC AREA
44. 6.44 CHINA MARKET ANALYSIS BY END-USE
45. 6.45 INDIA MARKET ANALYSIS BY SERVICE
46. 6.46 INDIA MARKET ANALYSIS BY MEDICAL DEVICES
47. 6.47 INDIA MARKET ANALYSIS BY THERAPEUTIC AREA
48. 6.48 INDIA MARKET ANALYSIS BY END-USE
49. 6.49 JAPAN MARKET ANALYSIS BY SERVICE
50. 6.50 JAPAN MARKET ANALYSIS BY MEDICAL DEVICES
51. 6.51 JAPAN MARKET ANALYSIS BY THERAPEUTIC AREA
52. 6.52 JAPAN MARKET ANALYSIS BY END-USE
53. 6.53 SOUTH KOREA MARKET ANALYSIS BY SERVICE
54. 6.54 SOUTH KOREA MARKET ANALYSIS BY MEDICAL DEVICES
55. 6.55 SOUTH KOREA MARKET ANALYSIS BY THERAPEUTIC AREA
56. 6.56 SOUTH KOREA MARKET ANALYSIS BY END-USE
57. 6.57 MALAYSIA MARKET ANALYSIS BY SERVICE
58. 6.58 MALAYSIA MARKET ANALYSIS BY MEDICAL DEVICES
59. 6.59 MALAYSIA MARKET ANALYSIS BY THERAPEUTIC AREA
60. 6.60 MALAYSIA MARKET ANALYSIS BY END-USE
61. 6.61 THAILAND MARKET ANALYSIS BY SERVICE
62. 6.62 THAILAND MARKET ANALYSIS BY MEDICAL DEVICES
63. 6.63 THAILAND MARKET ANALYSIS BY THERAPEUTIC AREA
64. 6.64 THAILAND MARKET ANALYSIS BY END-USE
65. 6.65 INDONESIA MARKET ANALYSIS BY SERVICE
66. 6.66 INDONESIA MARKET ANALYSIS BY MEDICAL DEVICES
67. 6.67 INDONESIA MARKET ANALYSIS BY THERAPEUTIC AREA
68. 6.68 INDONESIA MARKET ANALYSIS BY END-USE
69. 6.69 REST OF APAC MARKET ANALYSIS BY SERVICE
70. 6.70 REST OF APAC MARKET ANALYSIS BY MEDICAL DEVICES
71. 6.71 REST OF APAC MARKET ANALYSIS BY THERAPEUTIC AREA
72. 6.72 REST OF APAC MARKET ANALYSIS BY END-USE
73. 6.73 SOUTH AMERICA MARKET ANALYSIS
74. 6.74 BRAZIL MARKET ANALYSIS BY SERVICE
75. 6.75 BRAZIL MARKET ANALYSIS BY MEDICAL DEVICES
76. 6.76 BRAZIL MARKET ANALYSIS BY THERAPEUTIC AREA
77. 6.77 BRAZIL MARKET ANALYSIS BY END-USE
78. 6.78 MEXICO MARKET ANALYSIS BY SERVICE
79. 6.79 MEXICO MARKET ANALYSIS BY MEDICAL DEVICES
80. 6.80 MEXICO MARKET ANALYSIS BY THERAPEUTIC AREA
81. 6.81 MEXICO MARKET ANALYSIS BY END-USE
82. 6.82 ARGENTINA MARKET ANALYSIS BY SERVICE
83. 6.83 ARGENTINA MARKET ANALYSIS BY MEDICAL DEVICES
84. 6.84 ARGENTINA MARKET ANALYSIS BY THERAPEUTIC AREA
85. 6.85 ARGENTINA MARKET ANALYSIS BY END-USE
86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY SERVICE
87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY MEDICAL DEVICES
88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY THERAPEUTIC AREA
89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USE
90. 6.90 MEA MARKET ANALYSIS
91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY SERVICE
92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY MEDICAL DEVICES
93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY THERAPEUTIC AREA
94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY END-USE
95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY SERVICE
96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY MEDICAL DEVICES
97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY THERAPEUTIC AREA
98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY END-USE
99. 6.99 REST OF MEA MARKET ANALYSIS BY SERVICE
100. 6.100 REST OF MEA MARKET ANALYSIS BY MEDICAL DEVICES
101. 6.101 REST OF MEA MARKET ANALYSIS BY THERAPEUTIC AREA
102. 6.102 REST OF MEA MARKET ANALYSIS BY END-USE
103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
104. 6.104 RESEARCH PROCESS OF MRFR
105. 6.105 DRO ANALYSIS OF HEALTHCARE
106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
109. 6.109 HEALTHCARE, BY SERVICE, 2024 (% SHARE)
110. 6.110 HEALTHCARE, BY SERVICE, 2024 TO 2035 (USD Billion)
111. 6.111 HEALTHCARE, BY MEDICAL DEVICES, 2024 (% SHARE)
112. 6.112 HEALTHCARE, BY MEDICAL DEVICES, 2024 TO 2035 (USD Billion)
113. 6.113 HEALTHCARE, BY THERAPEUTIC AREA, 2024 (% SHARE)
114. 6.114 HEALTHCARE, BY THERAPEUTIC AREA, 2024 TO 2035 (USD Billion)
115. 6.115 HEALTHCARE, BY END-USE, 2024 (% SHARE)
116. 6.116 HEALTHCARE, BY END-USE, 2024 TO 2035 (USD Billion)
117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.2.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.2.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.2.4 BY END-USE, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.3.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.3.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.3.4 BY END-USE, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.4.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.4.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.4.4 BY END-USE, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.5.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.5.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.5.4 BY END-USE, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.6.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.6.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.6.4 BY END-USE, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.7.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.7.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.7.4 BY END-USE, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.8.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.8.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.8.4 BY END-USE, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.9.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.9.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.9.4 BY END-USE, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.10.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.10.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.10.4 BY END-USE, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.11.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.11.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.11.4 BY END-USE, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.12.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.12.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.12.4 BY END-USE, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.13.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.13.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.13.4 BY END-USE, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.14.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.14.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.14.4 BY END-USE, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.15.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.15.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.15.4 BY END-USE, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.16.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.16.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.16.4 BY END-USE, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.17.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.17.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.17.4 BY END-USE, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.18.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.18.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.18.4 BY END-USE, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.19.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.19.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.19.4 BY END-USE, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.20.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.20.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.20.4 BY END-USE, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.21.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.21.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.21.4 BY END-USE, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.22.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.22.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.22.4 BY END-USE, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.23.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.23.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.23.4 BY END-USE, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.24.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.24.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.24.4 BY END-USE, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.25.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.25.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.25.4 BY END-USE, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.26.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.26.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.26.4 BY END-USE, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.27.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.27.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.27.4 BY END-USE, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.28.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.28.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.28.4 BY END-USE, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.29.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.29.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.29.4 BY END-USE, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY SERVICE, 2025-2035 (USD Billion)
  2. 7.30.2 BY MEDICAL DEVICES, 2025-2035 (USD Billion)
  3. 7.30.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.30.4 BY END-USE, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Medical Device Design Development Services Market Segmentation

Medical Device Design Development Services Market By Service (USD Billion, 2025-2035)

Designing & Engineering
Machining
Molding
Packaging

Medical Device Design Development Services Market By Medical Device Design Development Services Markets (USD Billion, 2025-2035)

Cardiovascular Devices
POC Diagnostic Equipment
Hb1Ac Testing
Drug Delivery Devices
Orthopedic Devices
Dental Devices
Surgical Devices
Imaging Devices
Sleep & Respiratory Devices
Ophthalmology Devices
Endoscopy
Diabetes Care
Cochlear Implants
Neurostimulators
Others

Medical Device Design Development Services Market By Therapeutic Area (USD Billion, 2025-2035)

Cardiovascular
Diagnostic
Others

Medical Device Design Development Services Market By End-Use (USD Billion, 2025-2035)

Medical Device Design Development Services Market Companies
Biotechnology Companies

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”

Guilherme Gomes Martins Product Management Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035